Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1989;36(5):517-20.
doi: 10.1007/BF00558079.

Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers

Affiliations
Comparative Study

Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers

N Inotsume et al. Eur J Clin Pharmacol. 1989.

Abstract

The pharmacokinetics of the H2-receptor antagonist famotidine, after oral administration of a 20 mg tablet, has been studied in 10 elderly patients with normal renal function (CLCR greater than or equal to 59 ml.min-1, Mean = 80 ml.min-1), 5 elderly patients with renal insufficiency (CLCR less than or equal to 38 ml.min-1, Mean = 15 ml.min-1), and 6 healthy young volunteers. Elimination half-life in the elderly patients with renal insufficiency was significantly prolonged compared to the elderly patients with normal renal function and the young volunteers. The correlation coefficient between creatinine clearance and the elimination rate constant of famotidine was 0.672. Mean urinary recovery of unchanged drug up to 24 h in the young volunteers was 44%. The mean renal clearance of famotidine in the young volunteers (270 ml.min-1) was substantially greater than the creatinine clearance, 128 ml.min-1, which suggests the possibility of tubular secretion of famotidine.

PubMed Disclaimer

References

    1. Digestion. 1985;32 Suppl 1:15-23 - PubMed
    1. Eur J Clin Pharmacol. 1985;28(3):327-31 - PubMed
    1. Dig Dis Sci. 1985 Apr;30(4):308-12 - PubMed
    1. Clin Pharmacol Ther. 1983 Apr;33(4):445-52 - PubMed
    1. Br J Clin Pharmacol. 1987 Sep;24(3):385-9 - PubMed

Publication types

LinkOut - more resources